Clinical Trial Update: Reducing Breathlessness With Dronabinol in COPD Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating dronabinol to reduce breathlessness in COPD patients is active/not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breathlessness
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Dronabinol (dronabinol)

Snippet

Sponsor: Vejle Hospital | Conditions: COPD, Breathlessness | Phase 3 | Status: ACTIVE_NOT_RECRUITING